학술논문
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
Document Type
Article
Author
Raspagliesi, Francesco; Melichar, Bohuslav; Gaba Garcia, Lydia; Jackson, Amanda; Henry, Stephanie; Kral, Zdenek; Harter, Philipp; De Giorgi, Ugo; Bjurberg, Maria; Gold, Michael; O'Malley, David; Honhon, Brigitte; Vulsteke, Christof; De Cuypere, Eveline; Denys, Hannelore; Baurain, Jean-Francois; Zamagni, Claudio; Tenney, Meaghan; Gordinier, Mary; Bradley, William; Schlumbrecht, Matthew; Spirtos, Nicola; Concin, Nicole; Mahner, Sven; Scambia, Giovanni; Leath, Charles; Farias-Eisner, Robin; Cohen, Joshua; Muller, Carolyn; Bhatia, Sumeet; Coleman, Robert L ; Lorusso, Domenica; Gennigens, Christine; González-Martín, Antonio; Randall, Leslie; Cibula, David; Lund, Bente; Woelber, Linn; Pignata, Sandro; Forget, Frederic; Redondo, Andrés; Vindeløv, Signe Diness; Chen, Menghui; Harris, Jeffrey R; Smith, Margaret; Nicacio, Leonardo Viana; Teng, Melinda S L; Laenen, Annouschka; Rangwala, Reshma; Manso, Luis; Mirza, Mansoor; Monk, Bradley J; Vergote, Ignace
Source
In The Lancet Oncology May 2021 22(5):609-619
Subject
Language
ISSN
1470-2045